Global Microbiome Sequencing Services Market Size Research Report to 2025Posted by Ainsley Lewis on November 15th, 2017 According to the latest market report published by Credence Research, Inc. “Microbiome Sequencing Services Market - Growth, Future Prospects, and Competitive Analysis, 2017 - 2025,” the global microbiome sequencing services market was valued at US$ 498 Mn in 2016, and is expected to reach US$ 2,519.3 Mn by 2025, expanding at a CAGR of 19.6% from 2017 to 2025. Market Insights: Microbiome sequencing is used to study microflora of human biota with the goal of understanding of human microbes and role played by them in health and disease. Earlier traditional microbiological techniques were used for sample from skin, blood or stool sample, to study the phenotype and genotype of the individual. With advent of technology, tool such as next generation sequencing is used to generate data of human microbiome. This kind of throughput would help in metagenomics studies. Microbiome are considered as major indication of any alteration that take place in body. Browse the full report Microbiome Sequencing Services Market - Growth, Future Prospects and Competitive Analysis, 2017 – 2025 report at http://www.credenceresearch.com/report/microbiome-sequencing-services-market Monitoring the human microbial biota, genes or output such as protein or metabolites help in measuring the disease status and predicting individual response to the treatment. Novel high-throughput sequencing and new software tools are revolutionizing microbiome study and help in providing service at high quality, speed and effective cost. Human microbiome sequencing services would be of help in commercialization of personalized medicine and diet. The global microbiome sequencing services market is segmented by technology type into shotgun sequencing, targeted gene sequencing, RNA sequencing, whole genome sequencing and others. Shotgun sequencing dominates the microbiome sequencing services market. The global microbiome sequencing services market is segmented by application type into therapeutics, genetic screening, drug and biomarker discovery, personalised medicine and others. Therapeutics segment dominates the microbiome sequencing services market with rising prevalence of cancer and infectious diseases. Based on research type, this market is classified as outsourced and in-house. Outsourced research segment occupies the large share and highest CAGR microbiome sequencing services market in the given forecast period. The global microbiome sequencing services market is segmented by end users into pharmaceutical and biotechnology companies, academia/research institutes and others. Pharmaceutical and biotechnology companies segment dominate the microbiome sequencing services market due to rise in funding by government and venture capitalist in research and development. As of the current market scenario, North America dominates the global microbiome sequencing services market followed by the Europe. Evolving sequencing technology, increase in government funding in genomic studies and analyses, growing interest in microbiome sequencing for exploring personalized medicine and prevention and treatment of disease are some of the major factors driving the growth of microbiome sequencing services market in North America and Europe. Asia Pacific is the fastest growing regional market for microbiome sequencing services with highest CAGR in the forecast period. Market Competition Assessment: Key players in the global microbiome sequencing services market are Baseclear B.V., Clinical-Microbiomics A/S, Diversigen, Inc., Merieux Nutrisciences Corporation, Metabiomics Corp., Microbiome Therapeutics, LLC, Microbiome Insights Inc., Molzym GmbH & Co. Kg, MR DNA (Molecular Research Lp), Openbiome, Shanghai Realbio Technology Co., Ltd, Rancho Biosciences, Resphera Biosciences, LLC, Ubiome, Inc., Zymo Research Corp. and others. Key Market Movements: Growing interest in microbiome sequencing and its application in therapeutic, personalized medicine, smart drug delivery system is the key factor responsible for microbiome sequencing services market. Rise in prevalence of cancer, chronic diseases, infectious diseases also responsible for growth of microbiome sequencing services market. About Us: Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task. Who we are Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals. Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa. Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect. What we do We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability. No matter the challenge, we concentrate on delivering functional and persevering results and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist works straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies. Contact: Name: Chris Smith Designation: Global Sales Manager Ph: 1-800-361-8290 Email: sales@credenceresearch.com Web: http://www.credenceresearch.com/ Like it? Share it! More by this author |